Save time and get answers to complex questions with AI chat
Testosterone enanthate expiration?Dabrafenib patent expiration?What is dabrafenib mesylate msn patent issue?When is xarelto's patent set to expire roughly?When will a generic version of xiaflex be available?
See the DrugPatentWatch profile for methylphenidate
“Methylphenidate osm er” is shorthand for an extended-release formulation of methylphenidate (often written as “methylphenidate OSM ER” on prescriptions or packaging). OSM commonly refers to an oral drug-delivery system used in certain extended-release products, designed to release methylphenidate over an extended period. Methylphenidate is a central nervous system stimulant used to treat attention-deficit/hyperactivity disorder (ADHD) in children and adults, and in some cases narcolepsy.
It’s the same active medication (methylphenidate) but not necessarily the same product. Different extended-release methylphenidate brands use different release technologies and have different dosing strengths and instructions. That means the “OSM ER” product may not be interchangeable milligram-for-milligram with other extended-release methylphenidate products.
Extended-release methylphenidate is intended to start working after dosing and then keep releasing medication to help cover symptoms for much of the day rather than lasting only a few hours (as with immediate-release forms).
To identify the exact product and dosing instructions, check: - The full brand name (if present) - The strength (mg) - Whether it says extended-release / “ER” - Any specific tablet/capsule instructions (for example, some extended-release forms have rules about swallowing whole and not crushing) If you share the exact label text (brand name and strength), I can tell you what that specific “methylphenidate osm er” product corresponds to and how it’s typically used.
Other Questions About Methylphenidate :